Trump's Planned Board for NIH Grants: What Would Change and Why It Matters
President Donald Trump is expected to issue an executive order creating a board to approve National Institutes of Health grant funding. The Guardian
The proposal would set up an outside committee with power to veto biomedical research awards that do not align with Trump's goals. The board would include Office of Management and Budget Director Russell Vought, who oversees federal spending, and NIH Director Jay Bhattacharya. Decisions would require unanimity, meaning all members must agree. The NIH sits inside the Department of Health and Human Services. It is the world's largest public funder of biomedical research. The draft deals with control of billions of dollars in NIH science grants. The New York Times
Trump told Vought to write the order during an Oval Office meeting on Friday. Politico Vought had pressed for closer scrutiny of NIH grants in an Oval Office clash. He argued the NIH has funded "woke" priorities. He proposed that the president create a commission to review NIH grants. The Washington Post
In a separate exchange, Trump asked Bhattacharya to cut Harvard's funding. Bhattacharya refused.
If issued, the order would extend a pattern of intervention in research funding. The administration flagged research containing keywords including 'equity,' 'racist,' 'gender' and 'climate change' to hinder funding for scientific research. Researchers filed a class-action lawsuit alleging the administration hindered and terminated science grants to censor opposing views in violation of the First Amendment.
Budget pressure has run alongside. The administration proposed a 40 percent cut to the NIH budget. Trump sought to cut more than $4 billion in payments to universities for administrative and facilities costs, the overhead that keeps labs and buildings running.
Three earlier White House directives give administrative context. The White House published a presidential action titled 'Improving Oversight of Federal Grantmaking' on federal grantmaking oversight. It published a presidential action titled 'Restoring Gold Standard Science' on scientific integrity policies and data transparency. It issued Executive Order 14292 on May 5, 2025, titled 'Improving the Safety and Security of Biological Research'.
The broader context here is who gets the final say. Putting award approval with a small board that includes the budget director shifts final discretion away from the agency and department system that has managed NIH awards. Like a second lock on a door, unanimity gives each member a veto. Applicants would need both political and scientific sign-off before money moves.
Looking at what this could mean for research institutions, the Harvard refusal and the pending First Amendment case will shape how any order is received. Universities already face proposed cuts to overhead payments plus grant terminations tied to keyword screening. A central approval board would add another gate. It would also leave a clear paper trail for courts to review. How that record fits with the existing oversight directives will decide whether the board works as coordination or control.
